← Back to Eli Lilly and Company
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19397018 | METHODS OF CLEANING CHROMATOGRAPHY MATRICES | PARIHAR, PRADHUMAN | 1714 | §103 | Non-Final OA | — | Pending | Nov 21, 2025 |
| 19477673 | METHODS AND SYSTEMS FOR MANAGING DIABETES | BALAJ, ANTHONY MICHAEL | 3682 | §101§103 | Non-Final OA | — | Pending | Oct 22, 2025 |
| 19348544 | PEPTIDES FOR INCRETIN SYNTHESIS | D' AMBROSIO, THEA | 1654 | §102§103 | Non-Final OA | — | Pending | Oct 02, 2025 |
| 19104909 | INFUSION SITE FAILURE DETECTION | SHELDEN, BION A | 3685 | §101§112 | Final Rejection | 31d overdue | AI Ready | Feb 19, 2025 |
| 18950247 | TECHNIQUES FOR PROCESSING WIRELESSLY BROADCAST PACKETS FROM A MEDICAL DEVICE WITH DOSE-RELATED DATA | GILLIGAN, CHRISTOPHER L | 3683 | §101§112 | Final Rejection | 63d | Pending | Nov 18, 2024 |
| 18864287 | GLP1 TABLET COMPOSITIONS | ALAWADI, SARAH | 1619 | §112DP | Non-Final OA | — | Pending | Nov 08, 2024 |
| 18933587 | FARNESOID X RECEPTOR AGONISTS AND USES THEREOF | ISMAIL, REHANA | 1625 | §112DP | Non-Final OA | — | Pending | Oct 31, 2024 |
| 18857347 | FGFR2 INHIBITOR COMPOUNDS | FETTEROLF, BRANDON J | — | §112 | Non-Final OA | — | Pending | Oct 16, 2024 |
| 18828945 | GLUCAGON-LIKE PEPTIDE1 RECEPTOR AGONISTS | COUGHLIN, MATTHEW P | 1626 | §102§103§112Other | Non-Final OA | — | Pending | Sep 09, 2024 |
| 18826275 | AT2R ANTAGONISTS AND USES THEREOF | ISMAIL, REHANA | 1625 | DP | Non-Final OA | — | Pending | Sep 06, 2024 |
| 18745159 | MEDICATION DELIVERY DEVICE WITH GEAR SET DOSAGE SYSTEM | MENDEZ, MANUEL A | 3783 | §103§112 | Non-Final OA | — | Pending | Jun 17, 2024 |
| 18713758 | SYSTEMS AND METHODS FOR IDENTIFYING SUBJECTS FOR CLINICAL TRIALS | HEIN, DEVIN C | 3686 | §101 | Final Rejection | 33d | Pending | May 28, 2024 |
| 18612180 | METHODS OF PRODUCING FC-CONTAINING PROTEINS | KONOPELSKI SNAVEL, SARA ELIZABETH | 1658 | §102§103§112DP | Non-Final OA | — | Pending | Mar 21, 2024 |
| 18595872 | CONNECTED INJECTION DEVICES WITH STATUS SENSING SYSTEMS | VARGAS, ANNA ELIZABETH | 3783 | §102 | Non-Final OA | 70d | Pending | Mar 05, 2024 |
| 18686475 | SYSTEMS AND METHODS FOR SENSING DEFECATION EVENTS | OKONAK, ELIZABETH LOUISE | 3792 | §103 | Final Rejection | 27d | Pending | Feb 26, 2024 |
| 18684025 | THERAPEUTIC AGENT DELIVERY DEVICE | PATEL, SHEFALI DILIP | 3783 | §102§103§112 | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18428443 | PROCESSES FOR THE PREPARATION OF SELECTIVE ESTROGEN RECEPTOR DEGRADERS | WITHERSPOON, SIKARL A | 1692 | Other | Final Rejection | — | Pending | Jan 31, 2024 |
| 18428102 | GIP/GLP1/GCG TRI-RECEPTOR AGONISTS AND USES THEREOF | DABKOWSKI, ERINNE R | 1654 | §103§112DP | Non-Final OA | — | Pending | Jan 31, 2024 |
| 18409277 | THERAPEUTIC USES OF DULAGLUTIDE | CHANDRA, GYAN | 1674 | §102§103DP | Non-Final OA | — | Pending | Jan 10, 2024 |
| 18571825 | COMPOSITIONS OF EXTENDED RELEASE COATINGS AND METHODS FOR APPLYING EXTENDED RELEASE COATINGS | RODRIGUEZ, CRIS LOIREN | 3783 | §103 | Non-Final OA | — | Pending | Dec 19, 2023 |
| 18571397 | METHODS FOR TREATING OBSTRUCTIVE SLEEP APNEA | HAMA, JOANNE | 1647 | §103§112 | Non-Final OA | — | Pending | Dec 18, 2023 |
| 18531856 | GITR ANTAGONISTS AND METHODS OF USING THE SAME | ESSEX, LAURA ANN | 1675 | DP | Non-Final OA | — | Pending | Dec 07, 2023 |
| 18565484 | METHOD FOR TREATING IDH INHIBITOR-RESISTANT SUBJECTS | O DELL, DAVID K | 1621 | §102§103Other | Non-Final OA | 61d | Pending | Nov 29, 2023 |
| 18501175 | AHR AGONISTS | COPPINS, JANET L | 1628 | §112 | Non-Final OA | — | Pending | Nov 03, 2023 |
| 18549693 | USE OF MEVIDALEN AND OTHER D1 POSITIVE ALLOSTERIC MODULATORS FOR SLOWING OF PARKINSON'S DISEASE PROGRESSION | ELENISTE, PIERRE PAUL | 1622 | §103§112DP | Final Rejection | 60d overdue | Pending | Sep 08, 2023 |
| 18549803 | ANTI-AMYLOID BETA ANTIBODIES AND USES THEREOF | WEIDNER, ADAM M | 1675 | §102§103§112Other | Non-Final OA | — | Pending | Sep 08, 2023 |
| 18547460 | SELF-ASPIRATING SYRINGE SYSTEMS, CARTRIDGES, AND METHODS | AHMED, TASNIM M | 3783 | §102§103 | Final Rejection | — | Pending | Aug 22, 2023 |
| 18546483 | GIP/GLP1 DUAL AGONIST THERAPEUTIC METHODS | HELLMAN, KRISTINA M | 1654 | §103§112DP | Non-Final OA | — | Pending | Aug 15, 2023 |
| 18366061 | TRANSFERRIN RECEPTOR BINDING PROTEINS AND CONJUGATES | TAYLOR, LIA ELAN | 1641 | §101§112DP | Non-Final OA | — | Pending | Aug 07, 2023 |
| 18344134 | KRAS G12C INHIBITOR DOSING REGIMENS | FERGUSON, JALISA HOLMES | 1626 | §103§112Other | Non-Final OA | — | Pending | Jun 29, 2023 |
| 18258698 | RNA THERAPEUTICS AND METHODS OF USE THEREOF | SHIN, DANA H | 1635 | §112 | Final Rejection | — | Pending | Jun 21, 2023 |
| 18258462 | Therapeutic Peptide Formulations | KOMATSU, LI N | 1658 | §103§112DP | Non-Final OA | 56d | Pending | Jun 20, 2023 |
| 18258018 | HUB FOR REUSABLE DRUG-DELIVERY DEVICE | ACKUN, JACOB K | 3783 | §102§103§112 | Non-Final OA | — | Pending | Jun 16, 2023 |
| 18266717 | METHODS OF TREATING DIABETES | YANG, TIAN | 1674 | §112 | Non-Final OA | — | Pending | Jun 12, 2023 |
| 18323674 | LASOFOXIFENE COMBINATION TREATMENT OF ER+ BREAST CANCER THAT HAS PROGRESSED ON A CDK4/6 INHIBITOR | NOTTINGHAM, KYLE GREGORY | 1621 | §102§103§112 | Final Rejection | 22d overdue | Pending | May 25, 2023 |
| 18297099 | COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34 | NICKOL, GARY B | 1643 | Other | Non-Final OA | — | Pending | Apr 07, 2023 |
| 18247198 | METHODS FOR REDUCING HOST CELL PROTEIN CONTENT IN ANTIBODY PURIFICATION PROCESSES AND ANTIBODY COMPOSITIONS HAVING REDUCED HOST CELL PROTEIN CONTENT | SZPERKA, MICHAEL EDWARD | 1641 | §103§112DP | Non-Final OA | — | Pending | Mar 29, 2023 |
| 18041898 | METHODS AND APPARATUS FOR DISPLAYING GLUCOSE DATA | HANEY, JONATHAN MICHAEL | 3791 | §103 | Non-Final OA | — | Pending | Feb 16, 2023 |
| 17787015 | ENDOTOXIN DETECTION | FRITCHMAN, REBECCA M | 1758 | §103 | Final Rejection | 118d overdue | Pending | Feb 06, 2023 |
| 18040282 | MEDICATION DELIVERY DEVICE WITH SENSING SYSTEM | SCHMIDT, EMILY LOUISE | 3783 | §103 | Non-Final OA | — | Pending | Feb 02, 2023 |
| 18005245 | LOW DOSE REGIMEN AND FORMULATION OF A 5-METHYL-1,2,4-OXADIAZOL-3-YL COMPOUND | MOU, LIYUAN | 1628 | §103§112Other | Final Rejection | 34d | Pending | Jan 12, 2023 |
| 17920118 | PAN-ELR+ CXC CHEMOKINE ANTIBODIES FOR THE TREATMENT OF RESPIRATORY DISEASE | SAOUD, CHRISTINE J | 1645 | §103Other | Non-Final OA | — | Pending | Oct 20, 2022 |
| 17905580 | SUBCUTANEOUS ABSORPTION AND BIOAVAILABILITY OF ANTIBODIES | GAO, ASHLEY HARTMAN | 1678 | §101§103§112 | Final Rejection | — | Pending | Sep 02, 2022 |
| 17905520 | MULTISPECIFIC BINDING PROTEINS AND METHODS OF DEVELOPING THE SAME | ROONEY, NORA MAUREEN | 1641 | §112 | Final Rejection | 42d overdue | Pending | Sep 02, 2022 |
| 17883072 | Anti-CGRP Antibody Formulation | WANG, CHANG YU | 1675 | §112 | Non-Final OA | 14d | Pending | Aug 08, 2022 |
| 17795797 | THERAPEUTIC USES OF DULAGLUTIDE | HA, JULIE | 1654 | §103§112 | Non-Final OA | — | Pending | Jul 27, 2022 |
| 17711099 | ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF | BALLARD, KIMBERLY | 1675 | §103§112DP | Non-Final OA | — | Pending | Apr 01, 2022 |
| 17554713 | Anti-CGRP Antibody Formulation | BORGEEST, CHRISTINA M | 1675 | §103Other | Non-Final OA | 4d overdue | Pending | Dec 17, 2021 |
| 17535059 | COMPOUNDS AND METHODS TARGETING HUMAN TAU | BALLARD, KIMBERLY | 1675 | §112 | Non-Final OA | — | Pending | Nov 24, 2021 |
| 17507414 | METHODS OF TREATING CROHN'S DISEASE | GUSTILO, ESTELLA M | 1646 | §103§112Other | Non-Final OA | — | Pending | Oct 21, 2021 |
| 17439066 | INTEGRATED INSERTER/APPLICATOR FOR A DRUG DELIVERY SYSTEM PROVIDING MULTIPLE WEAR CONFIGURATIONS | THOMAN, EVELYN ANNE | 3783 | §103 | Final Rejection | 29d | Pending | Sep 14, 2021 |
| 17438692 | PRESERVED FORMULATIONS | REYNOLDS, FRED H | 1658 | §103§112Other | Non-Final OA | — | Pending | Sep 13, 2021 |
